| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |